Replies to post #664344 on NorthWest Biotherapeutics Inc (NWBO)

[Margin Buu]

https://www.england.nhs.uk/wp-content/uploads/2023/12/23-25NHSPS-amendment-consultation-annex.xlsx
"Proposed amendments to the 2023/25 NHS Payment Scheme - Consultation Annex"
Tab: Proposed 24-25 HC drugs
High cost drugs - proposed list for 2024/25

The table below lists drugs that are excluded from NHSPS price calculations.

Details of drugs commissioned by NHS England Specialised Commissioning are available from 'Indications for NHS England drugs list' on the webpage: www.england.nhs.uk/commissioning/spec-services/key-docs/

Please note: For 2024/25, we are proposing to add named cancer drugs and advanced medicinal products (ATMP) items. These items are listed below. They were previously covered by a category description and so there is no change in how they should be reimbursed.

Drugs excluded from NHSPS price calculations:
Row 125
Drug Name:Murcidencel (strikethrough "Brain cancer vaccine")
Cell is Color Coded Blue = Changes made since 2023/24 to item remaining on the high cost drugs list
Group: Advanced Medicinal Products (ATMP)

[mike00h]

Don't know your answer, but anyone can check here to see our application is not yet approved.
https://www.gov.uk/government/collections/marketing-authorisations-lists-of-granted-licences

It's bimonthly and last update in Jan 9., which was posted on Jan. 17, 2024.